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CORRECTION Open Access
Correction: ASPM-associated stem cell
proliferation is involved in malignant
progression of gliomas and constitutes
an attractive therapeutic target
Sandra-Nadia Ngwabyt Bikeye1, Carole Colin2, Yannick Marie1, Raphaël Vampouille4, Philippe Ravassard4,
Audrey Rousseau5, Blandine Boisselier1, Ahmed Idbaih1,3, Charles Félix Calvo1, Pascal Leuraud6, Myriam Lassalle6,
Soufiane El Hallani1, Jean-Yves Delattre1,3 and Marc Sanson1,3*
Correction
In the original article [1], the additional file two: figure S.
Two (additional file 1 here) contained two identical
graphs. We present here the corrected figure S2 and the
corresponding legend:
Additional material
Additional file 1: Tumor spheroid characterization. Genomic stability
was examined with CGHa analysis (left = DNA profile from the initial
tumor; right = DNA profile from gliomasphere at passage p28). The
chromosomes are indicated on the × axis and copy number is on y axis.
Yellow indicates the normal genomic copy number, while green
indicates a loss and red indicates a gain in copy number. Although some
differences are observed, the comparison of both profiles shows that
overall genomic profile is quite well preserved (except for an amplicon
on chromosome 8 present only in the gliomasphere).
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